Calithera Biosci Com (CALA)

$3.33 0.00 (0.00%)

19:59 EST CALA Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 119.36M

PE Ratio -3.36

EPS -0.99

Volume (Avg. Vol.)

Day's Range 3.33 - 3.33

52-Week Range 2.46 - 8.18

Dividend & Yield N/A (N/A)

CALA Stock Predictions, Articles, and Calithera Biosci Com News

From InvestorPlace
From the Web

5 Stocks to Add to Your Portfolio on New Analyst Coverage

By Zacks Investment Research Oct 10, 2017

Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

12 Health Care Stocks Moving In Friday's Intraday Session

From Benzinga Jan 15, 2021

Gainers ObsEva (NASDAQ:OBSV) shares rose 57.51% to $3.97 during Friday's regular session. ObsEva's stock is trading at a volume of 92.5 million shares as of 12:32...

The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

From Benzinga Jan 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X Genomics Inc (NASDAQ:...

70 Biggest Movers From Yesterday

From Benzinga Jan 15, 2021

Gainers Poshmark, Inc. (NASDAQ: POSH) shares climbed 141.7% to close at $101.50 on Thursday as the company priced its IPO at $42 per share. Lexicon Pharmaceuticals, Inc. (NASDAQ...

Implied Volatility Surging for Calithera Biosciences (CALA) Stock Options

From Zacks Investment Research Jan 13, 2021

Investors need to pay close attention to Calithera Biosciences (CALA) stock based on the movements in the options market lately.

A Buy the Dip Stock Trigger in Calithera Biosciences Inc

From Capital Market Laboratories Jan 13, 2021

The Techncial Trigger Driven Stock Trade in Calithera Biosciences Inc (NASDAQ:CALA) .

Biotech Stock Roundup: MRNA's COVID-19 Vaccine Updates & Other Pipeline Updates

From Zacks Investment Research Jan 6, 2021

The biotech sector was in focus last week with COVID-19 vaccine study updates from Moderna (MRNA) and other regulatory updates.

Navellier Ratings

Total Grade

Strong Sell

Calithera Biosci Com (CALA)

CALA Stock Predictions, Articles, and Calithera Biosci Com News

5 Stocks to Add to Your Portfolio on New Analyst Coverage

12 Health Care Stocks Moving In Friday's Intraday Session

The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

70 Biggest Movers From Yesterday

Implied Volatility Surging for Calithera Biosciences (CALA) Stock Options

A Buy the Dip Stock Trigger in Calithera Biosciences Inc

Biotech Stock Roundup: MRNA's COVID-19 Vaccine Updates & Other Pipeline Updates

Navellier Ratings

Total Grade

Subscriber Sign in